1. Home
  2. AVTX vs OPAL Comparison

AVTX vs OPAL Comparison

Compare AVTX & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • OPAL
  • Stock Information
  • Founded
  • AVTX 2011
  • OPAL 1998
  • Country
  • AVTX United States
  • OPAL United States
  • Employees
  • AVTX N/A
  • OPAL N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • OPAL Natural Gas Distribution
  • Sector
  • AVTX Health Care
  • OPAL Utilities
  • Exchange
  • AVTX Nasdaq
  • OPAL Nasdaq
  • Market Cap
  • AVTX 88.4M
  • OPAL 87.0M
  • IPO Year
  • AVTX 2015
  • OPAL N/A
  • Fundamental
  • Price
  • AVTX $7.35
  • OPAL $3.10
  • Analyst Decision
  • AVTX Strong Buy
  • OPAL Buy
  • Analyst Count
  • AVTX 4
  • OPAL 5
  • Target Price
  • AVTX $33.00
  • OPAL $6.78
  • AVG Volume (30 Days)
  • AVTX 54.4K
  • OPAL 129.7K
  • Earning Date
  • AVTX 03-28-2025
  • OPAL 03-12-2025
  • Dividend Yield
  • AVTX N/A
  • OPAL N/A
  • EPS Growth
  • AVTX N/A
  • OPAL N/A
  • EPS
  • AVTX N/A
  • OPAL 0.18
  • Revenue
  • AVTX $820,000.00
  • OPAL $306,957,000.00
  • Revenue This Year
  • AVTX N/A
  • OPAL $23.40
  • Revenue Next Year
  • AVTX N/A
  • OPAL $29.66
  • P/E Ratio
  • AVTX N/A
  • OPAL $17.58
  • Revenue Growth
  • AVTX N/A
  • OPAL 30.17
  • 52 Week Low
  • AVTX $4.18
  • OPAL $2.91
  • 52 Week High
  • AVTX $34.46
  • OPAL $5.18
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 42.79
  • OPAL 47.96
  • Support Level
  • AVTX $7.42
  • OPAL $2.94
  • Resistance Level
  • AVTX $8.50
  • OPAL $3.19
  • Average True Range (ATR)
  • AVTX 0.64
  • OPAL 0.10
  • MACD
  • AVTX 0.02
  • OPAL 0.02
  • Stochastic Oscillator
  • AVTX 17.16
  • OPAL 67.39

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

Share on Social Networks: